Genfosis Update
News & Articles
China’s Breakthrough in Diabetes Treatment: Stem Cell Therapy for a Future Without Insulin
Chinese scientists have developed a pioneering stem cell therapy that could transform diabetes care worldwide. Early trials show that patients with both Type 1 and Type 2 diabetes became insulin-free within weeks. This breakthrough not only brings new hope to over 500 million patients but also poses significant challenges to the global healthcare system and pharmaceutical industry.
Revolutionary Down Syndrome Treatment: CRISPR-Cas9 Successfully Eliminates Extra Chromosomes
A groundbreaking technique from Japan may redefine the future of Down syndrome treatment. CRISPR-Cas9 has been used to successfully eliminate the extra chromosome in human cells. What was once impossible may now be within reach.
Longevity Technology 2026 | 5 Emerging Health Tech Trends for Clinics
Explore 5 top longevity tech trends of 2026 — biological age testing, AI health coaching, multi-omics personalization
CP Innovation Exposition & Symposium 2025
CEO of Genfosis presented Longevity Technology and strategies for longer, healthier lives at CP Innovation Exposition & Symposium 2025.
Health & Innovation Asia 2025
Genfosis presented BioSmart testing and our vision for science-backed future food solutions at Health & Innovation Asia 2025.
Job & Study Fair GS KKU x Industrial Partners
Genfosis participated in the Job & Study Fair hosted by the Graduate School of Khon Kaen University in collaboration with industry partners.
Thailand WHO Simulation 2025
Genfosis joined the Thailand WHO Simulation 2025 to support the ethical use of AI in medicine.
Wellness & Longevity Program for Executives (WLE3)
Genfosis CEO Lectures on Precision Medicine at Executive Wellness Program
Genfosis's 'Longevity in Action' Event
Genfosis's 'Longevity in Action' Event Draws Top Public and Private Sector Leaders